Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Further Success for Link Technologies in Asia

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Japanese company GeneDesign joins growing list of distributors.

Following its announcement to expand into the Far East last month, certified specialist oligonucleotide reagent manufacturer Link Technologies Ltd, has agreed another distribution contract in Asia with Japanese company GeneDesign, Inc..

The deal comes just a few weeks after the signing of Zirench Technology for distribution in China.

Link Technologies is ISO 9001:2008 certified and manufacture a comprehensive range of reagents for DNA, RNA and PNA synthesis and modifications including a custom service for tailored compounds in specialist applications.

GeneDesign, located in Osaka, Japan, will represent Link Technologies throughout Japan and will be exhibiting at the forthcoming AsiaTIDES meeting on oligonucleotide and peptide research, technology and product development on February 26-28 in Tokyo, Japan.

Speaking about the agreement, Hideaki Sato, General Manager, Technical Support and Marketing at GeneDesign, Inc. said “Our collaboration with Link Technologies supports our goal of contributing to human welfare and health through nucleic acid technology development. We are delighted to be working with Link Technologies to increase the presence and usage of their high quality, reliable oligo precursor products in Japan. We invite people to visit us at the AsiaTIDES meeting to discover in detail the many benefits of these new offerings.”

Dr John Bremner, CEO at Link Technologies added “By working with GeneDesign we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan. This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our on-going strategic plans for development and growth. GeneDesign is a company that values the importance of this and we look forward to working with them.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Link Technologies Announces Partnership with American International Chemical
AIC to distribute Link’s specialist oligonucleotide modifiers in North America.
Wednesday, May 23, 2012
Link Technologies Secures Exclusive License for Ultra Sensitive Diagnostic Probes
Deal marks the start of ongoing collaboration between Link and The University of Manchester.
Tuesday, December 01, 2009
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Monday, May 18, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Researchers Can Control Genes Involved in Cancer
A new way to control the activity of a protein, that is often upregulated in cancer, has been discovered by Moffitt researchers through monoubiquitination mechanism.
Mitochondrial Role in Metastatic Cancer
Researchers have manipulated proteins, sourced from tumour cells, that are essential for maintaining tumour cells and in doing so, have significantly reduced the ability of cancer cells.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
Scientists Culture Elusive Yellowstone Microbe
ORNL scientists have successfully isolated and cultured a Yellowstone sourced acidic hot-spring based microbe.
Seeing RNA at the Nanoscale
MIT researchers have developed a new way to image proteins and RNA inside neurons of brain tissue.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!